Literature DB >> 15474766

Myasthenia gravis and pregnancy.

Emma Ciafaloni1, Janice M Massey.   

Abstract

Treatment considerations for women who have MG and are of childbearing age are complicated. When possible, before pregnancy, establishing a plan for therapy is ideal, recognizing the potential concerns for the patient and the fetus. Decisions about treatment during pregnancy must balance the potential complications for the fetus, the patient, and even the integrity of the pregnancy. Most women who have MG are able to complete pregnancy successfully and deliver a healthy baby; however, there always is some risk that NMG may occur. Pregnant patients who have MG are served best at centers capable of providing coordinated expert care from neurologic, obstetric, and pediatric providers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474766     DOI: 10.1016/j.ncl.2004.06.003

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  4 in total

1.  Pregnancy and delivery of a healthy baby in autoimmune Lambert-Eaton myasthenic syndrome.

Authors:  Christiane Schneider-Gold; Carsten Wessig; Martin Höpker; Bernhard Erdlenbruch; Ralf Gold; Klaus Toyka
Journal:  J Neurol       Date:  2006-04-05       Impact factor: 4.849

2.  Transient neonatal Lambert-Eaton syndrome.

Authors:  U Reuner; G Kamin; G Ramantani; H Reichmann; J Dinger
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 4.849

3.  Pregnancy complicating Wegener's granulomatosis.

Authors:  May Ching Soh; Hamish H Hart; Eileen Bass; Lucille Wilkinson
Journal:  Obstet Med       Date:  2009-05-22

Review 4.  Myasthaenia Gravis: Clinical management issues before, during and after pregnancy.

Authors:  Ali Hassan; Zakia M Yasawy
Journal:  Sultan Qaboos Univ Med J       Date:  2017-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.